These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 17704745

  • 21. C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice.
    Knight B, Tirnitz-Parker JE, Olynyk JK.
    Gastroenterology; 2008 Sep; 135(3):969-79, 979.e1. PubMed ID: 18602920
    [Abstract] [Full Text] [Related]

  • 22. [Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine].
    Huang YH, Zhang SH, Zhen RX, Xu XD, Zhen YS.
    Ai Zheng; 2004 Dec; 23(12):1599-604. PubMed ID: 15601545
    [Abstract] [Full Text] [Related]

  • 23. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H, Tan X, Dong Y, Giese A, Chou TC, Rainov N, Yang B.
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
    [Abstract] [Full Text] [Related]

  • 24. [Effect of tyrosine kinase inhibitor Imatinib mesylate on proliferation, differentiation and apoptosis of Kasumi-1 leukemia cell line].
    Wang LH, Rao Q, Wang M, Wang JX.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):449-52. PubMed ID: 16383232
    [Abstract] [Full Text] [Related]

  • 25. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 26. Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects.
    Rocha A, Azevedo I, Soares R.
    J Cell Biochem; 2008 Feb 01; 103(2):607-14. PubMed ID: 17614352
    [Abstract] [Full Text] [Related]

  • 27. Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.
    Xie XK, Yang DS, Ye ZM, Tao HM.
    Cancer Invest; 2006 Feb 01; 24(1):1-8. PubMed ID: 16466985
    [Abstract] [Full Text] [Related]

  • 28. Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway.
    Casado-Zapico S, Rodriguez-Blanco J, García-Santos G, Martín V, Sánchez-Sánchez AM, Antolín I, Rodriguez C.
    J Pineal Res; 2010 Jan 01; 48(1):72-80. PubMed ID: 20025643
    [Abstract] [Full Text] [Related]

  • 29. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Feb 01; 113(3):443-56. PubMed ID: 18327707
    [Abstract] [Full Text] [Related]

  • 30. Cisplatin enhances apoptosis induced by a tumor-selective adenovirus expressing tumor necrosis factor-related apoptosis-inducing ligand.
    Reddy RM, Tsai WS, Ziauddin MF, Zuo J, Cole GW, Maxhimer JB, Fang B, Schrump DS, Nguyen DM.
    J Thorac Cardiovasc Surg; 2004 Dec 01; 128(6):883-91. PubMed ID: 15573073
    [Abstract] [Full Text] [Related]

  • 31. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
    Engel JB, Honig A, Schönhals T, Weidler C, Häusler S, Krockenberger M, Grunewald TG, Dombrowski Y, Rieger L, Dietl J, Wischhusen J.
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov 01; 141(1):64-9. PubMed ID: 18687514
    [Abstract] [Full Text] [Related]

  • 32. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
    O'Connor K, Gill C, Tacke M, Rehmann FJ, Strohfeldt K, Sweeney N, Fitzpatrick JM, Watson RW.
    Apoptosis; 2006 Jul 01; 11(7):1205-14. PubMed ID: 16699961
    [Abstract] [Full Text] [Related]

  • 33. Osteoblast-conditioned medium promotes proliferation and sensitizes breast cancer cells to imatinib treatment.
    Brama M, Basciani S, Cherubini S, Mariani S, Migliaccio S, Arizzi M, Rosano G, Spera G, Gnessi L.
    Endocr Relat Cancer; 2007 Mar 01; 14(1):61-72. PubMed ID: 17395975
    [Abstract] [Full Text] [Related]

  • 34. Imatinib mesylate inhibits tumorigenicity of malignant fibrous histiocytoma cells in vivo.
    Irsan I, Akisue T, Hara H, Fujimoto T, Imabori M, Doita M, Kuroda R, Fujioka H, Kawamoto T, Yamamoto T, Kurosaka M.
    Anticancer Res; 2007 Mar 01; 27(1A):423-9. PubMed ID: 17352263
    [Abstract] [Full Text] [Related]

  • 35. Role of intracellular glutathione in cell sensitivity to the apoptosis induced by tumor necrosis factor {alpha}-related apoptosis-inducing ligand/anticancer drug combinations.
    Meurette O, Lefeuvre-Orfila L, Rebillard A, Lagadic-Gossmann D, Dimanche-Boitrel MT.
    Clin Cancer Res; 2005 Apr 15; 11(8):3075-83. PubMed ID: 15837763
    [Abstract] [Full Text] [Related]

  • 36. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.
    Gotlieb WH, Bruchim I, Gu J, Shi Y, Camirand A, Blouin MJ, Zhao Y, Pollak MN.
    Gynecol Oncol; 2006 Feb 15; 100(2):389-96. PubMed ID: 16300820
    [Abstract] [Full Text] [Related]

  • 37. Influence of imatinib mesylate on radiosensitivity of astrocytoma cells.
    Ranza E, Bertolotti A, Facoetti A, Mariotti L, Pasi F, Ottolenghi A, Nano R.
    Anticancer Res; 2009 Nov 15; 29(11):4575-8. PubMed ID: 20032406
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells.
    Bielawska A, Popławska B, Surazyński A, Czarnomysy R, Bielawski K.
    Eur J Pharmacol; 2010 Sep 15; 643(1):34-41. PubMed ID: 20598681
    [Abstract] [Full Text] [Related]

  • 40. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
    González-Sánchez I, Lira-Rocha A, Navarrete A, Loza-Mejía MA, Coronel-Cruz C, Mendoza-Rodríguez CA, Cerbón MA.
    Anticancer Res; 2012 Dec 15; 32(12):5159-65. PubMed ID: 23225412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.